LDL-C Assessment: A Novel, More Accurate Estimate to Inform Clinical Decision-Making
Clinical Testing for Titin and Ryanodine Receptor Autoantibodies in Myasthenia Gravis Patients
   A new study supports assessment of family history and genetic predisposition in addition to established cardiometabolic risk factors.
Geographic Disparities in Access to Syringe Services Programs Among Young People with Hepatitis C Virus Infection in the US
Myasthenia Gravis
Improving the Positive Predictive Value of Noninvasive Prenatal Screening (NIPS)

Browse by Medical Specialty


Modernizing the LDL-C Calculation to Improve Patient Care

Dr Martin will explain the limitations of Friedewald-estimated LDL cholesterol and identify patients in whom it is less accurate, and to be able to recognize... Read more 


New Guidelines and Offerings for Expanded Carrier Screening

Dr. Kathryn Gray discusses traditional carrier screening and expanded carrier screening and describes the recommendations for expanded carrier screening. Read more 


QHerit™ Overview

Quest Diagnostics Genetic Counselor Lisa Blazejewski, MS, CGC, presents an overview on the QHerit™ expanded carrier screening panel. Read more 

Search Webinars

Concurrent Use of Opioids and Benzodiazepines: Evaluation of Prescription Drug Monitoring by a United States Laboratory

Quest Diagnostics Authors: Gudin, J, Kaufman, HW, McClure, FL

Authors: Niles JKNassar A, Cohen C, Zhou W, Lynch KA, Barker EA, Vanderbilt BL, Thompson J, Heyman ER, Olson A, Lange H, Siddiqui MT.

Journal of Addiction Medicine

Specialties: Toxicology/Pain Management

Read the Key Summary (Download PDF)

Biomarkers in sports and exercise: tracking health, performance, and recovery in athletes.

Quest Diagnostics Authors: Fragala, M

J Strength Cond Res. 2017 Jul 19. doi: 10.1519/JSC.0000000000002122. [Epub ahead of print]

Specialties: Sports Medicine